Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ramona Rorig"'
Autor:
Thomas M Schindler, Frank Grieger, Anna Zak, Ramona Rorig, Kavya Chowdary Konka, Anna Ellsworth, Christopher Pfitzer, Keir Hodge, Christine Crandall, TransCelerate Clinical Research Access & Information Exchange Initiative
Publikováno v:
PLoS ONE, Vol 15, Iss 5, p e0233294 (2020)
ClinicalTrials.gov was started with the intention to create a consumer-friendly database for patients and others in search of information on clinical trials. However, there is no research on whether the content of ClinicalTrials.gov aligns with patie
Externí odkaz:
https://doaj.org/article/dcd4cb3c65294a0188d39274f149fb15
Autor:
Shobha Dhadda, Stephen K. Tyring, Anna Wald, Ramona Rorig, Kazumasa Takenouchi, Neddie Zadeikis
Publikováno v:
The Journal of Infectious Diseases. 205:1100-1110
Background. Current therapies for genital herpes have only partial efficacy. Helicase-primase inhibitors are novel, potent inhibitors of herpes simplex virus replication. Methods. This randomized trial assessed the safety and efficacy of ASP2151 for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a79a7fb615a9896c2d4d7c83581c4a9e
https://doi.org/10.1093/infdis/jis019
https://doi.org/10.1093/infdis/jis019
Autor:
Michael J. Demeure, Tanya Fleege, Srinivasu Poondru, Jihong Chen, Cristina L. Ronchi, Eric Baudin, Francis P. Worden, Harm R. Haak, Martin Fassnacht, Jill Gilbert, Elizabeth Hesseltine, Gary D. Hammer, Alfredo Berruti, A. W. Stephens, Ramona Rorig, David I. Quinn, Massimo Terzolo, Toni K. Choueiri, Matthias Kroiss
Publikováno v:
Lancet oncology, 16(4), 426-435. Elsevier Science
Summary Background Adrenocortical carcinoma is a rare, aggressive cancer for which few treatment options are available. Linsitinib (OSI-906) is a potent, oral small molecule inhibitor of both IGF-1R and the insulin receptor, which has shown acceptabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::931e78c05083233aa70e3bda1d1a3f66
http://hdl.handle.net/2318/1534804
http://hdl.handle.net/2318/1534804
Autor:
Martin Fassnacht, Srinivasu Poondru, Michael J. Demeure, Tanya Fleege, Ramona Rorig, Eric Baudin, David I. Quinn, Gary D. Hammer, Alfredo Berruti
Publikováno v:
Journal of Clinical Oncology. 32:4507-4507
4507 Background: ACC is an uncommon but frequently fatal cancer. For pts with metastatic or recurrent nonoperable ACC, there are very limited treatment options. Insulin-like growth factor 2 (IGF2) ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7bcb65ffb6a7be0c00fd843158f6facf
https://doi.org/10.1200/jco.2014.32.15_suppl.4507
https://doi.org/10.1200/jco.2014.32.15_suppl.4507